← Back to Search

Embolization Agent

Prostate Artery Embolization for Enlarged Prostate

N/A
Waitlist Available
Led By Cliff Davis, MD
Research Sponsored by Tampa General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patient is aged 50-85 years
Patient has signed informed consent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up safety will be evaluated throughout the initial 12 months of the study by assessing adverse events and findings on physical examination.
Awards & highlights

Study Summary

This trial will test the effectiveness of a new treatment for enlarged prostate that is causing urinary problems.

Eligible Conditions
  • Enlarged Prostate

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~safety will be evaluated throughout the initial 12 months of the study by assessing adverse events and findings on physical examination.
This trial's timeline: 3 weeks for screening, Varies for treatment, and safety will be evaluated throughout the initial 12 months of the study by assessing adverse events and findings on physical examination. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Improvement of BPH symptoms as assessed by the IPSS at 12 months post PAE.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Prostate Artery EmbolizationExperimental Treatment1 Intervention
Embospheres microspheres

Find a Location

Who is running the clinical trial?

Tampa General HospitalLead Sponsor
19 Previous Clinical Trials
3,865 Total Patients Enrolled
Cliff Davis, MDPrincipal InvestigatorTampa General Hospital

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~3 spots leftby Mar 2025